Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Reducing Carotid IMT Progression in Pediatric SLE
NCT00065806Phase 3Completed
- Start
- Sep 2003
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in Mean-Mean Common Carotid Intima Media Thickness at 36 months. Started Sep 2003; status: completed.
02
Drugs
atorvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00065806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065806.